Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 56

1.
2.

Survey of International Members of the American Thoracic Society on Climate Change and Health.

Sarfaty M, Kreslake J, Ewart G, Guidotti TL, Thurston GD, Balmes JR, Maibach EW.

Ann Am Thorac Soc. 2016 Oct;13(10):1808-1813.

PMID:
27726439
3.

American Thoracic Society and Marron Institute Report. Estimated Excess Morbidity and Mortality Caused by Air Pollution above American Thoracic Society-Recommended Standards, 2011-2013.

Cromar KR, Gladson LA, Perlmutt LD, Ghazipura M, Ewart GW.

Ann Am Thorac Soc. 2016 Aug;13(8):1195-201. doi: 10.1513/AnnalsATS.201602-103AR.

PMID:
27509145
4.

Clinically Significant Pocket Hematoma Increases Long-Term Risk of Device Infection: BRUISE CONTROL INFECTION Study.

Essebag V, Verma A, Healey JS, Krahn AD, Kalfon E, Coutu B, Ayala-Paredes F, Tang AS, Sapp J, Sturmer M, Keren A, Wells GA, Birnie DH; BRUISE CONTROL Investigators.

J Am Coll Cardiol. 2016 Mar 22;67(11):1300-8. doi: 10.1016/j.jacc.2016.01.009.

5.

Effects of an In-Frame Deletion of the 6k Gene Locus from the Genome of Ross River Virus.

Taylor A, Melton JV, Herrero LJ, Thaa B, Karo-Astover L, Gage PW, Nelson MA, Sheng KC, Lidbury BA, Ewart GD, McInerney GM, Merits A, Mahalingam S.

J Virol. 2016 Mar 28;90(8):4150-9. doi: 10.1128/JVI.03192-15. Print 2016 Apr.

6.

The antiviral compound BIT225 inhibits HIV-1 replication in myeloid dendritic cells.

Khoury G, Ewart G, Luscombe C, Miller M, Wilkinson J.

AIDS Res Ther. 2016 Feb 8;13:7. doi: 10.1186/s12981-016-0093-z. eCollection 2016.

7.

A Phase 1b/2a study of the safety, pharmacokinetics and antiviral activity of BIT225 in patients with HIV-1 infection.

Wilkinson J, Ewart G, Luscombe C, McBride K, Ratanasuwan W, Miller M, Murphy RL.

J Antimicrob Chemother. 2016 Mar;71(3):731-8. doi: 10.1093/jac/dkv389. Epub 2015 Nov 29.

PMID:
26620101
8.

From closing the atmospheric ozone hole to reducing climate change. Lessons learned.

Ewart GW, Rom WN, Braman SS, Pinkerton KE.

Ann Am Thorac Soc. 2015 Feb;12(2):247-51. doi: 10.1513/AnnalsATS.201411-537PS.

PMID:
25706493
9.

American Thoracic Society member survey on climate change and health.

Sarfaty M, Bloodhart B, Ewart G, Thurston GD, Balmes JR, Guidotti TL, Maibach EW.

Ann Am Thorac Soc. 2015 Feb;12(2):274-8. doi: 10.1513/AnnalsATS.201410-460BC.

10.

Pacemaker or defibrillator surgery without interruption of anticoagulation.

Birnie DH, Healey JS, Wells GA, Verma A, Tang AS, Krahn AD, Simpson CS, Ayala-Paredes F, Coutu B, Leiria TL, Essebag V; BRUISE CONTROL Investigators.

N Engl J Med. 2013 May 30;368(22):2084-93. doi: 10.1056/NEJMoa1302946. Epub 2013 May 9.

11.

The public health benefits of air pollution control.

Li J, Ewart G, Kraft M, Finn PW.

J Allergy Clin Immunol. 2012 Jul;130(1):22-3. doi: 10.1016/j.jaci.2012.02.047. Epub 2012 Apr 21. No abstract available.

PMID:
22521246
12.

Evaluation of the Faraday angle by numerical methods and comparison with the Tore Supra and JET polarimeter electronics.

Brault C, Gil C, Boboc A, Spuig P; JET-EFDA Contributors.

Rev Sci Instrum. 2011 Apr;82(4):043502.

PMID:
21678660
13.

Detecting non-maxwellian electron velocity distributions at JET by high resolution Thomson scattering.

Beausang KV, Prunty SL, Scannell R, Beurskens MN, Walsh MJ, de la Luna E; JET EFDA Contributors.

Rev Sci Instrum. 2011 Mar;82(3):033514.

PMID:
21585113
14.

Cardiac-resynchronization therapy for mild-to-moderate heart failure.

Tang AS, Wells GA, Talajic M, Arnold MO, Sheldon R, Connolly S, Hohnloser SH, Nichol G, Birnie DH, Sapp JL, Yee R, Healey JS, Rouleau JL; Resynchronization-Defibrillation for Ambulatory Heart Failure Trial Investigators.

N Engl J Med. 2010 Dec 16;363(25):2385-95. doi: 10.1056/NEJMoa1009540. Epub 2010 Nov 14.

15.

Tackling a root cause of chronic lung disease: the ATS, FDA, and tobacco control.

Wewers ME, Munzer A, Ewart G.

Am J Respir Crit Care Med. 2010 Jun 15;181(12):1281-2. doi: 10.1164/rccm.201004-0559ED. No abstract available.

PMID:
20558639
16.

An official American Thoracic Society policy statement: pay-for-performance in pulmonary, critical care, and sleep medicine.

Kahn JM, Scales DC, Au DH, Carson SS, Curtis JR, Dudley RA, Iwashyna TJ, Krishnan JA, Maurer JR, Mularski R, Popovich J Jr, Rubenfeld GD, Sinuff T, Heffner JE; American Thoracic Society Pay-for-Performance Working Group.

Am J Respir Crit Care Med. 2010 Apr 1;181(7):752-61. doi: 10.1164/rccm.200903-0450ST. Erratum in: Am J Respir Crit Care Med. 2010 Dec 1;182(11):1456. Sinuff, Tasnim [added].

PMID:
20335385
17.

Ligand-protein docking studies of potential HIV-1 drug compounds using the algorithm FlexX.

Patargias G, Ewart G, Luscombe C, Fischer WB.

Anal Bioanal Chem. 2010 Apr;396(7):2559-63. doi: 10.1007/s00216-010-3498-x. Epub 2010 Feb 18.

PMID:
20165836
18.

A novel Hepatitis C virus p7 ion channel inhibitor, BIT225, inhibits bovine viral diarrhea virus in vitro and shows synergism with recombinant interferon-alpha-2b and nucleoside analogues.

Luscombe CA, Huang Z, Murray MG, Miller M, Wilkinson J, Ewart GD.

Antiviral Res. 2010 May;86(2):144-53. doi: 10.1016/j.antiviral.2010.02.312. Epub 2010 Feb 13.

PMID:
20156486
19.

A second chance. Setting a protective ozone standard.

Dey R, Van Winkle L, Ewart G, Balmes J, Pinkerton K; ATS Environmental Health Policy Committee.

Am J Respir Crit Care Med. 2010 Feb 15;181(4):297-9. doi: 10.1164/rccm.201001-0032ED. No abstract available.

PMID:
20130144
20.

Antiviral efficacy of the novel compound BIT225 against HIV-1 release from human macrophages.

Khoury G, Ewart G, Luscombe C, Miller M, Wilkinson J.

Antimicrob Agents Chemother. 2010 Feb;54(2):835-45. doi: 10.1128/AAC.01308-09. Epub 2009 Dec 7.

Supplemental Content

Loading ...
Support Center